title: "Omics" and Immunologic Approaches to Optimizing Cure Rates in HER2-Positive Breast Carcinomas.
authors.affiliation: Molecular Targeting Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori , Milan , Italy.
authors.forename: Elda
authors.initials: E
authors.lastname: Tagliabue
authors.affiliation: Molecular Targeting Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori , Milan , Italy.
authors.forename: Manuela
authors.initials: M
authors.lastname: Campiglio
keywords: HER2; breast cancer; omics; targeted therapy; trastuzumab resistance